Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice

被引:0
|
作者
Pamela J. Skinner
Cynthia A. Vierra-Green
Effat Emamian
Huda Y. Zoghbi
Harry T. Orr
机构
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Department of Genetics, Cell and Developmental Biology
[3] University of Minnesota,Institute of Human Genetics
[4] Baylor College of Medicine,Departments of Pediatrics, and Molecular and Human Genetics, Howard Hughes Medical Institute
来源
NeuroMolecular Medicine | 2002年 / 1卷
关键词
ataxia; polyglutamine; SCA1; disease progression;
D O I
暂无
中图分类号
学科分类号
摘要
Spinocerebellar ataxia type 1 (SCA1) belongs to a family of polyglutamine induced neurodegenerative disorders. Transgenic mice that overexpress a mutant allele of the SCA1 gene develop a progressive ataxia and Purkinje cell pathology. In this report, the pathological importance of a segment of ataxin-1 previously shown to be important for protein-protein interactions was examined. While the absence of a 122 amino acid segment from the protein-protein interaction region of ataxin-1 did not effect the initiation of disease, its absence substantially suppressed the progression of disease in SCA1 transgenic mice. Thus, these data suggest that this region of ataxin-1 has a role in disease progression. Furthermore, these results provide evidence that ataxin-1-induced disease initiation and disease progression involve distinct molecular events.
引用
收藏
页码:33 / 42
页数:9
相关论文
共 50 条
  • [31] Experience of mGluR1 Gene Therapy in Transgenic Models of SCA1 Mice
    Shuvaev, A. N.
    Hirai, H.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2016, 8 (04) : 143 - 156
  • [32] Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua
    Kim, Eunji
    Lu, Hsiang-Chih
    Zoghbi, Huda Y.
    Song, Ji-Joon
    GENES & DEVELOPMENT, 2013, 27 (06) : 590 - 595
  • [33] In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
    Oez, Guelin
    Vollmers, Manda L.
    Nelson, Christopher D.
    Shanley, Ryan
    Eberly, Lynn E.
    Orr, Harry T.
    Clark, H. Brent
    EXPERIMENTAL NEUROLOGY, 2011, 232 (02) : 290 - 298
  • [34] Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways
    Ingram, Melissa
    Wozniak, Emily A. L.
    Duvick, Lisa
    Yang, Rendong
    Bergmann, Paul
    Carson, Robert
    O'Callaghan, Brennon
    Zoghbi, Huda Y.
    Henzler, Christine
    Orr, Harry T.
    NEURON, 2016, 89 (06) : 1194 - 1207
  • [35] SCA1-like Disease in Mice Expressing Wild-Type Ataxin-1 with a Serine to Aspartic Acid Replacement at Residue 776
    Duvick, Lisa
    Barnes, Justin
    Ebner, Blake
    Agrawa, Smita
    Andresen, Michael
    Lim, Janghoo
    Giesler, Glenn J.
    Zoghbi, Huda Y.
    Orr, Harry T.
    NEURON, 2010, 67 (06) : 929 - 935
  • [36] Altered trafficking of membrane proteins in Purkinje cells of SCA1 transgenic mice
    Skinner, PJ
    Vierra-Green, CA
    Clark, HB
    Zoghbi, HY
    Orr, HT
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03): : 905 - 913
  • [37] Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3ß-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1)
    Sanchez, Ivelisse
    Balague, Eudald
    Matilla-Duenas, Antoni
    HUMAN MOLECULAR GENETICS, 2016, 25 (18) : 4021 - 4040
  • [38] SCA1 TRANSGENIC MICE - A MODEL FOR NEURODEGENERATION CAUSED BY CAG TRINUCLEOTIDE EXPANSION
    BURRIGHT, EN
    CLARK, HB
    SERVADIO, A
    MATILLA, T
    FEDDERSEN, RM
    YUNIS, WS
    DUVICK, LA
    ZOGHBI, HY
    ORR, HT
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 8 - 8
  • [39] Prominent expression of spinocerebellar ataxia type-1 (SCA1) gene encoding ataxin-1 in LH-producing cells, LβT2
    Ogawa, S
    Aikawa, S
    Kato, T
    Tomizawa, K
    Tsukamura, H
    Maeda, K
    Petric, N
    Elsaesser, F
    Kato, Y
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2004, 50 (05): : 557 - 563
  • [40] Ataxin-1 with an expanded glutamine tract induces disease via alterations in nuclear function
    Orr, H
    Klement, I
    Skinner, P
    Davidson, J
    Burright, E
    Cummings, C
    Koshy, B
    Zoghbi, H
    FASEB JOURNAL, 1998, 12 (08): : A1322 - A1322